When.com Web Search

  1. Ads

    related to: vulvovaginal atrophy treatment
    • Menopause Quiz

      Find your stage of menopause.

      Take our simple quiz to learn more.

    • Reviews

      Hear from customers who have used

      Joylux's line of wellness products.

    • See Results

      Curious about our results?

      See our products' positive impact.

    • Blog

      Read our blog for more resources.

      Learn more about intimate wellness.

Search results

  1. Results From The WOW.Com Content Network
  2. Atrophic vaginitis - Wikipedia

    en.wikipedia.org/wiki/Atrophic_vaginitis

    Vulvovaginal atrophy and atrophic vaginitis have been the preferred terms for this condition and cluster of symptoms until recently. These terms are now regarded as inaccurate in describing changes to the entire genitourinary system occurring after menopause. The term atrophic vaginitis suggests that the vagina is inflamed or infected. Though ...

  3. Here's When You Need To See Your Doctor About Pain In Or ...

    www.aol.com/heres-why-vagina-hurting-according...

    Vulvovaginal atrophy is thinning, drying, and inflammation of the vaginal walls that can happen when your body produces less estrogen, most commonly after menopause (usually in women 50 or over ...

  4. Vaginitis - Wikipedia

    en.wikipedia.org/wiki/Vaginitis

    Vaginitis, also known as vulvovaginitis, is inflammation of the vagina and vulva. [4] [5] Symptoms may include itching, burning, pain, discharge, and a bad smell. [1]Certain types of vaginitis may result in complications during pregnancy.

  5. Prasterone - Wikipedia

    en.wikipedia.org/wiki/Prasterone

    In 2016, the FDA approved prasterone in an intravaginal gel formulation for the treatment of painful sexual intercourse due to vulvovaginal atrophy in the United States under the brand name Intrarosa. [72] [73] This was the first prasterone-containing medication to be approved by the FDA in this country. [72]

  6. Ospemifene - Wikipedia

    en.wikipedia.org/wiki/Ospemifene

    The trial patients were required to have one or more symptom of vulvovaginal atrophy (VVA) that was moderate or severe in nature with fewer than 5% of cells that were superficial when examined by a vaginal smear and a vaginal pH of at least 5.0. [15] This trial did not quantify relief of dyspareunia as a study outcome measure.

  7. Hormone replacement therapy - Wikipedia

    en.wikipedia.org/wiki/Hormone_replacement_therapy

    Vulvovaginal atrophyatrophic vaginitis and dryness; Dyspareunia – painful sexual intercourse due to vaginal atrophy and lack of lubrication; Bone loss – decreased bone mineral density, which can eventually lead to osteopenia, osteoporosis, and associated fractures; Decreased sexual desire

  1. Ad

    related to: vulvovaginal atrophy treatment